Obesity
ObesityWeek
The Obesity Society's 44th Annual Meeting
14–17 Nov 2026
Washington, D.C., USABooth #725
Research with purpose.
Results with impact.
A reliable site network driving quality data, precision recruitment and seamless execution for your trials.
Why Paratus
Why sponsors and CROs choose us
Sponsors choose Paratus for recruitment they can plan around, data they can rely on and start-up that keeps pace with their programme, delivered by a participant-first team that keeps people in the study.
Rapid study start-up
Approvals in as little as six weeks, compared to six months or more in many other regions.
The Australian advantage
Generous R&D incentives, with up to 43.5% tax refunds on eligible expenditure.
Purpose-built sites
Wholly owned, research-only sites near major hospitals, to ensure seamless execution.
Centralised core functions
Recruitment, quality & training, ethics, data management, feasibilities & contracts.
Extensive participant database
A large, consented pool of people who want to take part and are ready to engage.
Experienced team
Principal investigators and care teams that are trained to GCP.
Reliable recruitment
A strong track record of meeting and exceeding enrolment targets.
Results
Results sponsors can plan around
More than a decade of clinical research across our Australian network.
- 230+ clinical trials conducted
- 14+ therapeutic areas
- 13+ Million people within our network catchments
- 5 Australian research sites
- 10+ years of clinical research experience
Case study
From site initiation to first participant in just three days
0 days
from site initiation visit (SIV) to first participant in (FPI)
0
participants enrolled within 14 days
39 days ahead of target
15 JanStart
Ethics submission
2 FebDay 18
Ethics approval
3 FebDay 19
Research agreement signed and site initiation visit
4 FebDay 20
Site activated
6 FebDay 22
First participant in
20 FebDay 36
Last participant in: all 85 enrolled
End MarTarget
Sponsor's last-participant-in target
- 15 JanEthics submission
- 2 FebEthics approval
- 3 FebResearch agreement signed and site initiation visit
- 4 FebSite activated
- 6 FebFirst participant in
- 20 FebLast participant in: all 85 enrolled
- End MarSponsor's last-participant-in target
Trusted by sponsors and CROs
Testimonials
What our partners say
A true research partner
“Paratus approached our study as a genuine partner rather than simply another clinical site. Their team was engaged, responsive and proactive in working through challenges.”
Making complex studies easier
“Working with Paratus gave us a central point of contact and a team that understood both the operational requirements and the importance of keeping participants engaged.”
Recruitment you can rely on
“We appreciated Paratus's proactive approach, regular communication and willingness to explore practical solutions when recruitment became difficult.”
Professionalism that builds confidence
“What impressed us most was the professionalism of the Paratus team. Communication was clear, expectations were managed and issues were addressed constructively.”
Strong relationships, better collaboration
“Paratus's approachable team, collaborative mindset and commitment to good communication helped create a positive working relationship.”
A participant-centred research network
“Paratus's focus on the participant experience, combined with their operational approach, made them a valuable partner for our study.”
Ethics, quality & accessibility
Standards you can rely on
The statements sponsors and CROs ask about in due diligence, in one place.
Quality & GCP
Our dedicated Quality team supports consistent standards across our research sites through centralised oversight, structured quality review and a commitment to Good Clinical Practice.
How we maintain qualityEthics
Our dedicated Ethics team coordinates Human Research Ethics Committee (HREC) submissions, approvals and ongoing requirements to support ethical research and participant protection.
Ethics statementPrivacy & Data
We take the protection of participant information seriously, with established processes to support privacy, confidentiality and secure data handling throughout clinical research.
Privacy statementAccessibility
We aim to make clinical research information clear, inclusive and accessible, helping more people understand and explore opportunities to participate.
Our approach to accessibilityHow we work
From feasibility to close-out
- 1
Feasibility
We review your protocol and give a candid view of recruitment and timelines.
- 2
Start-up
Contracts, ethics and site activation run in parallel to save time.
- 3
Recruitment
Targeted outreach to our consented database and referral partners.
- 4
Delivery & retention
Participant-first care keeps people engaged through every visit.
- 5
Close-out
Clean data, on-time close-out and clear reporting.
Expertise
Phases and therapeutic areas
What happens at each stage of research.
I
Phase I
A small group checks safety and the right dose. Often open to healthy volunteers.
II
Phase II
A larger group looks at whether the treatment works and at side effects.
III
Phase III
Hundreds or thousands compare the treatment with the current standard of care.
IV
Phase IV
Monitoring continues after approval to learn more about long-term safety and benefit.
Congresses
Meet with us
We attend leading congresses. Book time with our team, or email us directly.
Prefer to talk now?
Book a 30-minute call with our business development team, no form needed.
Psychedelic science
CAPS27
Conference for Asia-Pacific Psychedelic Science
24–26 Feb 2027
Clinical operations
SCOPE Summit
Summit for Clinical Ops Executives
1–4 Mar 2027
Still have questions?
Our team is happy to talk it through. Call 1300 742 326.
Frequently asked questions
Answers to the questions sponsors and CROs ask most.
Paratus Clinical is an Australian clinical research site network supporting pharmaceutical, biotechnology and contract research organisation (CRO) partners in the delivery of clinical trials. We work with sponsors and CROs to identify suitable study opportunities, connect eligible participants with research opportunities and support the execution of clinical studies across our Australian sites.
Paratus Clinical has five Australian research sites in Brisbane, Canberra, the Central Coast, Melbourne and Western Sydney. Our network provides access to diverse metropolitan and regional populations, helping sponsors and CROs evaluate potential recruitment opportunities across multiple locations with coordinated study delivery and execution.
Our network supports clinical research across multiple therapeutic areas, including metabolic health and weight management, dermatology, vaccines, psychiatry and other indications aligned with our site capabilities. Therapeutic-area experience, investigator expertise and patient access are assessed against each study's specific requirements.
Contact our team to discuss your indication, protocol and site requirements.
Yes. We welcome enquiries from pharmaceutical and biotechnology sponsors, CROs and other clinical research partners. We work collaboratively to assess study requirements, site suitability, recruitment opportunities and operational needs.
Have a study to discuss?
Partner with Paratus Clinical to explore site feasibility, recruitment opportunities and clinical trial delivery across Australia. Contact our team to discuss your upcoming study.
Submit a studyLet's talk about your study
Tell us a little about your programme and timelines, and our business development team will reply with a named contact. Protocol details can wait until a confidentiality agreement is in place.
Research with purpose.
One purpose. Three ways to be part of it.
Participants, sponsors and healthcare professionals each play a role in bringing better treatments to the people who need them.
- 1
Participants
Be part of something bigger.
Your time helps bring tomorrow's treatments to the people who need them.
Explore - 2
Sponsors & CROs
Results with impact.
Reliable recruitment and quality data, so promising therapies reach patients sooner.
You are here - 3
Healthcare Professionals
Opportunities beyond standard care.
Open the door to new options for your patients, while they stay under your care.
Explore